The invention discloses novel application of a
quinazoline derivative type
tyrosine kinase inhibitor, belongs to the technical field of medicines, and in particular relates to novel application of a compound of a formula (I) shown in the description, and a stereisomer, a pharmaceutically acceptable salt and a
crystal forma thereof, and in the formula, R1, R2, R3, R4, R5, R6, L and n are defined inthe description. The invention specifically relates to the compounds and application of
medicine preparations and
medicine compositions with the compounds in preparing medicines for treating tumor patients with EGFR_T790M
mutation, EGFR_L858R
mutation, EGFR_C797S
mutation, EGFR_d746-750 mutation, EGFR_T790M / L858R mutation, EGFR_T790M / C797S mutation, EGFR_T790M / d746-750 mutation, EGFR_C797S / L858Rmutation, EGFR_L858R / d746-750 mutation, EGFR_C797S / d746-750 mutation, EGFR_L858R / T790M / C797S mutation, EGFT_d746-750 / T790M / C797S mutation or EGFR_d746-750 / L858R / C797S.